ARTICLE
TITLE

Breast Cancer Risk Analysis by the Use of Hormonal Contraceptives and Age of Menarche

SUMMARY

The number of cases of breast cancer is increasing every year and it’s a serious health problem in the world, including in Indonesia. Breast cancer is type of cancer that is most dominant in Indonesia. High estrogen exposure is one of factor that can increase the risk of breast cancer in women. This study was conducted to determine the relationship of estrogen exposure through the use of hormonal contraceptives and age of menarche with breast cancer incidence in women. Type of this study is observational analytic and use case control design. All of women breast cancer patients of Dr. Soetomo Hospital in 2013 were the population of case. All of woman non breast cancer patients who done breast examination at Dr Soetomo Hospital in 2013 were the population of control. The number of respondents in this study were 90 respondents were drawn from population using simple random sampling method. The variables studied were the use of hormonal contraceptives and age of menarche. The results of the analysis used binary logistic regression (a = 5%) indicated that the use of hormonal contraceptives (p = 0,028; OR = 3,266) and age of menarche (p =0,031; OR = 3,492) has an significant correlation with incidence of breast cancer in women at Dr. Soetomo Hospital in 2013. It is expected that the community can be more accurate in determining the duration of hormonal contraception usage and avoid lifestyle can accelerate the occurrence of menarche.Keywords: breast cancer, risk factor, hormonal contraceptives, age of menarche, estrogen

 Articles related

Andhika Rachman,Cosphiadi Irawan,Aditia R.R.,Sukamto Koesnoe,Indra Wijaya    

The cluster of differentiation 36 (CD36) is a multiligand receptor protein that plays a role in lipid metabolism. Its biological functions involve lipid uptake, immune recognition, inflammation, molecular adhesion, and tumor metastasis. Soluble CD36 (sCD... see more


Franja Dugar, Katja Goricar, Vita Dolžan, Tanja Marinko    

Breast cancer is a heterogeneous disease that can be treated by surgery, systemic therapy, and radiotherapy. Adjuvant breast cancer radiotherapy has important implications for patient survival but also causes adverse events. During radiation, not only ca... see more


Siti Fathurrohmah,G.A.B Yehezkiel P. Cahyadi,Firman Alamsyah,Rarastoeti Pratiwi    

Electro Capacitive Cancer Therapy (ECCT) is an electric field-based cancer therapy method using intermediate frequency (150 kHz) and low intensity (18 Vpp). High Mobility Group Box 1 (HMGB1) is a cytokine related to damage-associated molecular patterns (... see more


Asra Khan Pahore, Shagufta Khan, Nasim Karim    

Objective: To investigate the anticancer effect of Illicium verum against human breast cancer MCF-7 cell line.Methods: An experimental study was conducted in Multidisciplinary and Tissue Culture Laboratory, Aga Khan University in collaboration with Pharm... see more


Amel Elbasyouni,Leila Saadi,AbdelKarim Baha    

The inhibition of DNA methyltransferase-1 enzyme can strongly decrease the capacity of cells to enhance the tumour-genesis process. Members of the Estrogen-Related Receptors family regulate several elements of cellular metabolism. These are orphan nuclea... see more